CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2006-03-23): Percutaneous ablation offers advantages over surgery for small liver cancer

Clinical

Percutaneous ablation offers advantages over surgery for small liver cancer

Last Updated: 2006-03-23 13:40:14 -0400 (Reuters Health)

NEW YORK (Reuters Health) - As a treatment for solitary and small hepatocellular carcinoma (HCC), percutaneous local ablative therapy (PLAT) is just as effective as partial hepatectomy, but is associated with less postoperative pain and a much shorter hospital stay, new research shows.

With PLAT, a needle electrode is used to deliver ablative radiofrequencies to the tumor bed. The procedure is typically done using local anesthetics combined with intravenous sedation or epidural anesthesia. The present study is the first randomized prospective trial to compare PLAT as a treatment for small HCC with partial hepatectomy, the current gold standard.

The findings, which appear in the Annals of Surgery for March, are based on a study of 180 patients who were randomized to undergo PLAT or partial hepatectomy for a solitary HCC of no greater than 5 cm in diameter.

Nineteen of the 90 patients randomized to undergo PLAT withdrew their consent before the procedure was performed. The partial hepatectomies performed included a single Couinaud liver segment resection in 69 patients, 2 segments in 16 patients, and at least 3 segments in 3 patients.

The in-hospital mortality rates for the surgery and PLAT groups were 1.1% and 0%, respectively. Postoperative complications were more common in the surgery group and more severe, the report indicates.

No significant differences were seen between the groups in overall or disease-free survival. At 4 years, the overall and disease-free survival rates in each group hovered around 94% and 86%, respectively.

All patients in the surgery group required analgesics for pain control postoperatively compared with just 16 patients in the PLAT group (p < 0.05). Moreover, the average hospital stay after surgery was 19.7 days, nearly double the 9.18-day stay seen after PLAT (p < 0.05).

The results suggest that PLAT does not compromise survival outcomes and "has the advantage over liver resection in giving better short-term postoperative results because PLAT is a less invasive procedure," the authors conclude.

Ann Surg 2006;243:321-328.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.